How Effective are Metal Nanotherapeutic Platforms Against Bacterial Infections? A Comprehensive Review of Literature
DOI: https://doi.org/10.2147/IJN.S397298
IF: 7.033
2023-03-02
International Journal of Nanomedicine
Abstract:Ying Li, 1, 2, &ast Xiaomin Xia, 1, 2, &ast Wenxue Hou, 1, 2 Hanlin Lv, 1, 2 Jie Liu, 1, 2 Xue Li 1, 2 1 Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People's Republic of China; 2 School of Stomatology, Qingdao University, Qingdao, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xue Li, Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People's Republic of China, Tel +86-1 562 143 8983, Email The emergence of multidrug-resistant bacteria has been deemed a global crisis that affects humans worldwide. Novel anti-infection strategies are desperately needed because of the limitations of conventional antibiotics. However, the increasing gap between clinical demand and antimicrobial treatment innovation, as well as the membrane permeability obstacle especially in gram-negative bacteria fearfully restrict the reformation of antibacterial strategy. Metal-organic frameworks (MOFs) have the advantages of adjustable apertures, high drug-loading rates, tailorable structures, and superior biocompatibilities, enabling their utilization as drug delivery carriers in biotherapy applications. Additionally, the metal elements in MOFs are usually bactericidal. This article provides a review of the state-of-The-art design, the underlying antibacterial mechanisms and antibacterial applications of MOF- and MOF-based drug-loading materials. In addition, the existing problems and future perspectives of MOF- and MOF-based drug-loading materials are also discussed. Keywords: MOF, nanomaterial, antibacterial, mechanism, application Infectious diseases have for centuries been a tremendous obstacle to human progress and survival. They continue to rank among the world's leading causes of death and disability. 1 Infectious diseases have placed a tremendous financial and health burden on the entire world along with an ongoing background of unabating infections and the intermittent appearance of both new and old diseases. Due to their broad-spectrum antibacterial activities, antibiotics have been used to treat bacterial infections since Fleming discovered penicillin in 1928. 2 However, the increasing overuse and abuse of antibiotics has been found to have deleterious effects, the most prominent effect being the emergence of antibiotic resistance, which has been recognized as a global crisis, leading to more unfavourable prognoses and higher mortalities. 3–5 Even now, multidrug-resistant organisms (MDROs) account for up to 50% of the bacterial strains found in health care admission facilities. 6 Therefore, to overcome this difficult situation, further development of various antibacterial strategies is highly desired. 5 Nanotechnology has been increasingly used in sterilization and infection control during the past ten years as a result of the development of nanomaterials and nanotechnology. Due to their unique antimicrobial mechanisms, antibacterial nanomaterials were found to be less likely to cause bacterial resistance than conventional antibiotics. 7 Many nanomaterial agents, including metal nanoparticles (NPs) (eg, Ag-, Cu-, Mn-), metal oxide NPs (eg, CuO, ZnO, Fe 3 O 4 , TiO 2 ), and carbon-based nanomaterials (CNMs), have been found to have effective bactericidal functions. 7–12 The aforementioned antibacterial nanomaterials have impressive antibacterial activities, but they still have unignorable disadvantages. For example, metal NPs and metal oxide NPs have exhibited antibacterial effects by releasing metal ions, but the short duration of efficacy and the possibility of unexpected damage to normal cells due to the fast release of metal ions have limited their application. 13,14 Due to their diverse active sites and exceptional properties 15 (high surface area, chemical and thermal stability, tuneable pore sizes, and various functionalities on the internal surface), metal-organic frameworks, a class of microporous polymers made of metal nodes and organic linkers, have been extensively studied and tested for use in a variety of fields, such as the fields of environmental pollution, 16,17 gas adsorption, 18 catalysis, 19 and sensing platforms. 20 Its distinctive biodegradability, biocompatibility, and low toxicity have facilitated a wider range of biomedical applications. 21–24 Compared with other antibacterial agents, MOFs are unique in the following ways: 1) Their components, pore sizes, and structures can be adjusted according to -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology